Peptides represent a rapidly expanding frontier in modern therapeutic strategies, offering high specificity and favorable safety profiles. As a leading innovator in contract development and manufacturing, we provide comprehensive peptide CDMO solutions designed to accelerate your peptide candidates from concept to clinical and commercial reality. Building on our extensive capabilities in complex molecule manufacturing, including our broader CDMO Solutions and specialized expertise in areas like Precision Therapeutics CDMO Solutions, we offer unparalleled support for your peptide pipeline.
Overview of Peptide CDMO Solutions
Peptide synthesis and manufacturing present unique scientific and technical challenges distinct from small molecules or biologics. Success hinges on deep expertise in organic chemistry, process optimization, rigorous purification, and stringent analytical control throughout the development lifecycle. Our peptide CDMO solutions encompass the entire value chain – from preclinical research support to commercial-scale cGMP manufacturing. We specialize in handling complex sequences, including long-chain peptides, those containing challenging amino acids (e.g., Cys, Met, Trp), and incorporating non-natural modifications. Our integrated approach ensures seamless technology transfer, robust process scalability, and consistent delivery of high-purity peptide active pharmaceutical ingredients (APIs), mitigating risks and accelerating your program timelines.
Our Comprehensive Peptide CDMO Services
Peptide Design & Sequence Optimization
Our seasoned medicinal chemists and peptide scientists partner with you to refine your target sequence. We leverage advanced in silico tools to predict solubility, aggregation propensity, metabolic stability, and potential immunogenicity. We advise on strategic modifications – such as cyclization, stapling, incorporation of D-amino acids, or PEGylation – to enhance stability, bioavailability, and target engagement while preserving biological activity. This proactive design phase is crucial for developing manufacturable, stable, and efficacious peptide candidates, laying a robust foundation for downstream development.
Process Development & Scale-Up Expertise
Translating a synthetic route from the lab bench to full production demands rigorous and systematic process development. We specialize in optimizing solid-phase peptide synthesis (SPPS), including resin selection, coupling chemistries such as Fmoc/t-Bu, deprotection strategies, and cleavage conditions. By refining these critical steps, we focus on maximizing yield, minimizing deletion sequences and related impurities, and maintaining chiral integrity.
Beyond SPPS, our expertise extends to solution-phase synthesis as well as hybrid solid–solution approaches, enabling us to address more complex peptide targets.Supported by state-of-the-art kilo labs and pilot facilities, we conduct comprehensive process characterization and scale-up studies in realistic production environments. This allows us to identify and control critical process parameters (CPPs), ensuring robust, reproducible performance at manufacturing scale.
cGMP Manufacturing Capabilities
Our facilities house automated, large-scale SPPS synthesizers capable of producing multi-kilogram quantities of peptide API. We implement stringent controls throughout synthesis, cleavage, isolation, and crude peptide purification. Our purification capabilities feature preparative high-performance liquid chromatography (HPLC) systems with sophisticated fraction collection, optimized for resolving complex peptide mixtures and achieving consistently high purity specifications.
Rigorous Analytical Development & Quality Control
Characterizing peptides demands a sophisticated analytical toolkit. Our analytical development team creates and validates stability-indicating methods for identity, purity (HPLC/UPLC, CE), potency (bioassays, binding assays), impurities (including related substances and counterions), residual solvents, elemental impurities, and microbiological attributes. We also utilize advanced techniques like Mass Spectrometry (LC-MS, HRMS) for sequence confirmation, peptide mapping, and detailed impurity profiling.
Advanced Lyophilization & Packaging Solutions
Many peptide APIs require specialized handling due to stability considerations. We offer expert formulation support and lyophilization cycle development to ensure optimal solid-state stability for your bulk peptide drug substance.
Frequently Asked Questions (FAQ)
Q1: What is the typical timeline from process development to GMP delivery for a peptide API?
Timelines vary significantly based on peptide complexity (length, modifications), required scale, and the stage of development (clinical phase). Generally, process development and optimization for a complex peptide can take several months. Manufacturing, including synthesis, purification, lyophilization, and comprehensive QC testing under GMP, typically requires an additional 4-6 months for a substantial clinical batch. Early engagement allows us to provide a more precise project-specific timeline.
Q2: Can you handle peptides with multiple disulfide bonds or complex post-translational modifications (PTMs)?
Absolutely. We possess specialized expertise in the synthesis and controlled formation of disulfide bonds, employing selective protecting groups and precise oxidation/folding strategies. Our capabilities extend to complex PTMs such as phosphorylation, glycosylation, lipidation, and site-specific conjugation (e.g., fluorescent labels, toxins, albumin binders). Our analytical suite is equipped to fully characterize these intricate structures and confirm correct modification.
Our products and services are for research use only.
